Current Affairs - Science
Why should I study the current affairs questions and answers section on "Science" daily?
Read the daily current affairs questions and answers section on "Science" to enhance your general knowledge for clearing competitive examinations and placement interviews.
Where can I get the current affairs questions and answers section on "Science"?
IndiaBIX provides you with daily current affairs questions and answers with explanations.
Where can I get the current affairs MCQ questions and answers section on "Science" (objective type, multiple choice)?
Here you can find multiple-choice-type current affairs questions and answers on "Science" for your interviews and competitive examinations. All the CA questions are arranged in different categories, including date-wise.
How do I download the current affairs questions section on "Science" in PDF format?
You can download the current affairs quiz questions and answers section on "Science" as PDF files or eBooks.
How do I answer the current affairs quiz section on "Science"?
You can answer any current affairs quiz question on "Science" by reading this current affairs section daily.
Exercise : Science - Latest Current Affairs
- Science - Latest Current Affairs
1.
What is the name of the smart cancer drug developed by Indian scientists to selectively target tumour cells?
Answer: Option
Explanation:
RK-251 is a smart cancer drug developed through collaborative research led by the Institute of Advanced Study in Science and Technology (IASST), Guwahati, and IIT-Guwahati. The drug is designed to selectively activate inside cancer cells by responding to high levels of Reactive Oxygen Species (ROS), which are more abundant in such cells. Once activated, RK-251 releases the anticancer compound NBDHEX. The drug demonstrated high efficacy against triple-negative breast cancer, an aggressive form of the disease. Preclinical testing using zebrafish embryos showed zero toxicity, while fluorescence helped monitor drug activation in ROS-rich environments.
Date : 2026-08-21
2.
Which organisation developed India’s first indigenous African Swine Fever vaccine for pigs?
Answer: Option
Explanation:
ICAR (Indian Council of Agricultural Research) developed India’s first indigenous African Swine Fever (ASF) vaccine. The live attenuated vaccine was developed using the MA-104 cell line at ICAR–National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal. It was officially launched by Union Agriculture Minister Shivraj Singh Chouhan on ICAR Foundation Day 2026. The vaccine is expected to strengthen livestock biosecurity, reduce pig mortality and support pig farmers, particularly in the North-Eastern states that have faced severe ASF outbreaks since 2020.
Date : 2026-08-05
3.
In which city will India host the International Type 1 Diabetes Summit 2026 from July 30 to August 1, 2026?
Answer: Option
Explanation:
Jodhpur in Rajasthan will host the International Type 1 Diabetes Summit 2026 from July 30 to August 1, 2026. The three-day global conference will bring together leading diabetes specialists, researchers, policymakers, government officials, and patient representatives from countries including India, the USA, and Australia. Organised by Friends of Mewar, Breakthrough T1D, and the William J. Clinton Foundation, the summit will focus on improving access to affordable insulin, advancing diabetes technologies such as continuous glucose monitoring and insulin pumps, promoting digital health solutions, strengthening international research collaboration, and enhancing the quality of life for people living with Type 1 diabetes.
Date : 2026-07-24
4.
Which pharmaceutical company developed QDENGA, India's first approved dengue vaccine?
Answer: Option
Explanation:
QDENGA, developed by Takeda, became India's first approved dengue vaccine after receiving authorisation from the Drug Controller General of India (DCGI). The live attenuated vaccine provides protection against all four dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4) and is approved for individuals aged 4 to 60 years without requiring pre-vaccination screening. Administered in two doses, the vaccine demonstrated high efficacy in global clinical trials involving over 28,000 participants. It has already been approved in 43 countries, prequalified by the World Health Organisation (WHO), and is expected to significantly strengthen India's efforts to prevent dengue infections and related hospitalisations.
Date : 2026-07-21
5.
What is the name of the world's first once-daily oral PCSK9 inhibitor approved by the US FDA for adults with high cholesterol?
Answer: Option
Explanation:
Lipfendra (enlicitide) became the world's first once-daily oral PCSK9 inhibitor after receiving approval from the US Food and Drug Administration (FDA) on July 16, 2026. Developed by Merck, the medicine works by blocking the PCSK9 protein, allowing more LDL receptors in the liver to remove bad cholesterol from the bloodstream. Clinical trials showed that it reduced LDL cholesterol levels by 56% to 60%. It is intended for adults with hypercholesterolemia, including familial hypercholesterolemia, and is used alongside statins and a healthy diet to achieve better cholesterol control.
Date : 2026-07-19
Quick links
Quantitative Aptitude
Verbal (English)
Reasoning
Programming
Interview
Placement Papers